Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15177331 | 0.95 | HPGD (0.41) | HPGDALDH1A1MAPTLMNANPC1 | |
| SCHEMBL301013 | 0.92 | FAAH (0.50) | HPGDCA2CA1CA12CA7 | |
| SCHEMBL6501307 | 0.89 | FAAH (0.54) | HPGDCA2FAAHKDM4ERELA | |
| SCHEMBL10226704 | 0.89 | FAAH (0.54) | HPGDCA2FAAHKDM4ERELA | |
| SCHEMBL12639756 | 0.88 | FAAH (0.38) | HPGDALDH1A1MAPTLMNANPC1 | |
| SCHEMBL2735010 | 0.88 | RELA (0.43) | HPGDALDH1A1MAPTLMNANPC1 | |
| SCHEMBL2735014 | 0.88 | RELA (0.40) | HPGDALDH1A1MAPTLMNANPC1 | |
| SCHEMBL15958664 | 0.87 | FAAH (0.46) | HPGDCA2CA1CA12CA7 | |
| SCHEMBL3016236 | 0.87 | HPGD (0.39) | HPGDALDH1A1MAPTLMNANPC1 | |
| SCHEMBL14932179 | 0.85 | FAAH (0.50) | HPGDCA2FAAHKDM4ERELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8084613-B2 | Tetrazoyloxime derivative and plant disease control agent | NIPPON SODA CO., LTD. (JP) | 2011-12-27 | — | — | US | claimed |
| US-12019375-B2 | Photosensitive material and method of lithography | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2024-06-25 | — | — | US | disclosed |
| CN-114133367-B | Preparation method of sulfoxide imido dihydropyrone derivative | 大连理工常熟研究院有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-114133367-A | Preparation method of sulphoxide imino dihydropyrone derivatives | 大连理工常熟研究院有限公司 | 2022-03-04 | — | — | CN | disclosed |
| US-11163233-B2 | Chemically amplified positive type photoresist composition and pattern forming method using the same | MERCK PATENT GMBH (DE) | 2021-11-02 | — | — | US | disclosed |
| EP-3259992-B1 | AGROCHEMICAL COMPOSITION | NIPPON SODA CO (JP) | 2019-01-02 | — | — | EP | disclosed |
| EP-2687088-B1 | AQUEOUS HORTICULTURAL MICROBICIDAL COMPOSITION SUSPENSION | NIPPON SODA CO (JP) | 2018-08-01 | — | — | EP | disclosed |
| US-9926274-B2 | Process for producing substituted methylamine compound and triazine derivative | NIPPON SODA CO., LTD. (JP) | 2018-03-27 | — | — | US | disclosed |
| US-9885956-B2 | Pattern forming method, and, electronic device producing method and electronic device, each using the same | FUJIFILM CORPORATION (JP) | 2018-02-06 | — | — | US | disclosed |
| US-20180014543-A1 | AGROCHEMICAL COMPOSITION | NIPPON SODA CO., LTD. (JP) | 2018-01-18 | — | — | US | disclosed |
| US-7205083-B2 | Recording material | FUJIFILM CORPORATION (JP) | 2007-04-17 | — | — | US | disclosed |
| US-20070010493-A1 | Phospinite-imidazolines and metal complexes thereof | SOLVIAS AG (CH) | 2007-01-11 | — | — | US | disclosed |
| EP-1658298-A2 | NOVEL ORGANIC COMPOUNDS AND METAL COMPLEXES | Solvias AG (CH) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005021562-A2 | PHOSPINITE-IMIDAZOLINES AND METAL COMPLEXES THEREOF | SOLVIAS AG (CH) | 2005-03-10 | — | — | WO | disclosed |
| US-20050038035-A1 | Heterocyclic amide compounds as apolipoprotein b inhibitors | DAISO CO., LTD. (JP) | 2005-02-17 | — | — | US | disclosed |
| US-20040082472-A1 | Recording material | FUJI PHOTO FILM CO., LTD. | 2004-04-29 | — | — | US | disclosed |
| US-20040048185-A1 | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD | 2004-03-11 | — | — | US | disclosed |
| EP-1326835-A1 | BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-07-16 | — | — | EP | disclosed |
| WO-2002028835-A1 | BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-04-11 | — | — | WO | disclosed |
| US-6331628-B1 | REACTING A SUBSTITUTED HALOBENZENE WITH POTASSIUM, SODIUM AND/OR ZINC CYANIDE IN THE PRESENCE OF A METALLIC CATALYST | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2001-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010493-A1 | Phospinite-imidazolines and metal complexes thereof | H1-0, H1-2, H1-3 | HPGD 1914/4885ALDH1A1 2937/4885MAPT 4844/4885 |
| US-20180014543-A1 | AGROCHEMICAL COMPOSITION | CYP4B1, CMA1, CTRL | HPGD 3984/4885ALDH1A1 1770/4885MAPT 3691/4885 |
| US-20050038035-A1 | Heterocyclic amide compounds as apolipoprotein b inhibitors | APOB, APOL1, CTRB2 | HPGD 2564/4885ALDH1A1 1603/4885MAPT 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.